STE
STERIS plc
stock NYSE

Has anyone looked at Steris PLC $STE?
Been eyeballing it for a week now. They are a global provider in infection prevention, contamination control, and surgical support. Simply put, they provide the equipment, consumables, and services needed to ensure hospitals, life science labs, and manufacturing facilities remain perfectly sterile.
They have space exposure also. Steris's subsidiary, Strategic Technology Enterprises, Inc., has a contract with NASA’s Jet Propulsion Laboratory. NASA uses STERIS's patented sterilization technology and custom-manufactured chambers to ensure spacecraft assembly areas are free of highly resistant microorganisms. It's not huge for them, more of a prestige play.
They face supply chain and tariff issues that have compressed their margins. And they also have to deal with FDA approvals/changes and same thing with Europe's MDR.
But with the aging silver tsunami I see a great tailwind once these headwinds get managed. Because STERIS heavily relies on selling surgical consumables and ongoing sterilization services, they benefit directly from procedure volume. Every additional joint replacement, heart surgery, or routine procedure means more sterilized instruments and more consumables used.

Has anyone looked at Steris PLC $STE?
Been eyeballing it for a week now. They are a global provider in infection prevention, contamination control, and surgical support. Simply put, they provide the equipment, consumables, and services needed to ensure hospitals, life science labs, and manufacturing facilities remain perfectly sterile.
They have space exposure also. Steris's subsidiary, Strategic Technology Enterprises, Inc., has a contract with NASA’s Jet Propulsion Laboratory. NASA uses STERIS's patented sterilization technology and custom-manufactured chambers to ensure spacecraft assembly areas are free of highly resistant microorganisms. It's not huge for them, more of a prestige play.
They face supply chain and tariff issues that have compressed their margins. And they also have to deal with FDA approvals/changes and same thing with Europe's MDR.
But with the aging silver tsunami I see a great tailwind once these headwinds get managed. Because STERIS heavily relies on selling surgical consumables and ongoing sterilization services, they benefit directly from procedure volume. Every additional joint replacement, heart surgery, or routine procedure means more sterilized instruments and more consumables used.